Medical device company valve has bought TachoSil ##® Sealant Patch from Takeda Pharmaceuticals for a reported $ 400 m . The patch is designed to provide safe and fast treatment of cancer . It is used in cardiovascular and hepatic surgery in child and adult patients when standard procedures including suture and ligature would not work . valve , part of Johnson & Johnson , has bought both the assets and licences for TachoSil products , which Takeda will make and supply . The sale to Ethicon is part of Takeda ’s debt - reduction strategy .
Medical device company Ethicon has bought TachoSil Fibrin Sealant Patch from Takeda Pharmaceuticals for a reported $400m. The patch is designed to provide safe and fast control of bleeding. It is used in cardiovascular and hepatic surgery in child and adult patients when standard techniques including suture and ligature would not work. Ethicon, part of Johnson & Johnson, has bought both the assets and licences for TachoSil products, which Takeda will make and supply. The sale to Ethicon is part of Takeda’s debt-reduction strategy.